Intermediate-Acting Insulin is a type of pharmacological insulin formulation characterized by a delayed onset and prolonged duration of action, mediated through modifications such as crystallization or the addition of suspending agents like protamine, to provide basal insulin coverage over an extended period compared to short-acting insulins.
118
Publications
7.6K
Citations
568
Authors
214
Institutions
Publications per year
2017–2026
7
Parents
Publications
118
Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability
F. John Service, George D. Molnar, John W. Rosevear et al. · Diabetes · 1970 · 1K citations
Medicine, Endocrinology, Physiology +16
1–5 of 118
Authors
568
- RJRobert J. Heine
Amsterdam UMC Location Vrije Universiteit Amsterdam, Netherlands
5 publications · 209 citations
5
h-index
- HJ
3
h-index
- MB
3
h-index
- TD
2
h-index
- DK
2
h-index
1–5 of 568
Institutions
214
University of Amsterdam
Amsterdam, The Netherlands
4 h-index
18 publications
788 citations
Eli Lilly (United States)
Indianapolis, United States
3 h-index
7 publications
764 citations
University of Toronto
Toronto, Canada
3 h-index
5 publications
156 citations
University of Pittsburgh
Pittsburgh, United States
3 h-index
4 publications
219 citations
University of Michigan
Ann Arbor, United States
3 h-index
3 publications
537 citations
University of Helsinki
Helsinki, Finland
3 h-index
4 publications
826 citations
University of Minnesota
Minneapolis, United States
2 h-index
7 publications
6.2K citations
Diabetes-Akademie
Bad Mergentheim, Germany
2 h-index
4 publications
74 citations
1–8 of 214
Venues
- Diabetes Care
28 publications · 1.3K citations
20
h-index
- PubMed
Repository · 20 publications · 1.4K citations
16
h-index
- Diabetic Medicine
5 publications · 243 citations
5
h-index
- Diabetes
4 publications · 1.3K citations
4
h-index
- Current Medical Research and Opinion
CMRO · 3 publications · 121 citations
3
h-index
1–5